SCHEMBL7701095

SCHEMBL7701095

COC(=O)c1cccc2c1OCCC(C(=O)N=C(N)NOS(C)(=O)=O)=C2

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA9 Q16790 4/20 0.35
CA12 O43570 3/20 0.35
PARP1 P09874 1/20 0.34
TRPA1 O75762 2/20 0.33
KMT2A Q03164 2/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA5A P35218 1/20 0.32
KDM4E B2RXH2 3/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
TP53 P04637 1/20 0.31
NPC1 O15118 2/20 0.31
HTT P42858 2/20 0.31
POLB P06746 1/20 0.31
MAPT P10636 1/20 0.31
RAB9A P51151 1/20 0.31
NR1H4 Q96RI1 1/20 0.30
ALDH1A1 P00352 1/20 0.30
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7697135 0.92 PARP1 (0.43) PARP1KMT2AKDM4EALDH1A1HPGD
SCHEMBL7694853 0.90 PARP1 (0.34) PARP1KMT2A
SCHEMBL7701052 0.89 PARP1 (0.33) PARP1
SCHEMBL7700710 0.86 KMT2A (0.31) PARP1KMT2ANPC1RAB9A
SCHEMBL7701257 0.85 KMT2A (0.31) CA9PARP1KMT2ACA1CA2
SCHEMBL7701326 0.85 MTNR1A (0.33) CA9CA12KMT2ATP53MAPT
SCHEMBL7696930 0.84 KMT2A (0.31) KMT2A
SCHEMBL7702070 0.83 KMT2A (0.30) KMT2A
SCHEMBL7700530 0.83 MTNR1A (0.32) KMT2ATP53
SCHEMBL7696977 0.83 KMT2A (0.30) KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6346527-B1 1-BENZOXEPIN DERIVATIVES USED IN THE PREVENTION OF SODIUM AND HYDROGEN ION EXCHANGE; CARDIOVASCULAR, KIDNEY AND BRAIN DISORDER TREATMENT; ARTERIOSCLEROSIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-02-12 US disclosed